£1,000 buys 35 shares in The Motley Fool Uk’s incredibly reliable FTSE 100 dividend stock
The motley fool uk angle here is not just about a share price that has fallen sharply. It is about how a company can lose most of its market value and still keep acting like a dependable income machine. Croda International, a FTSE 100 chemicals company, has dropped 72% from its highs, yet it has continued to raise its dividend for more than 30 consecutive years. That tension between price damage and income resilience is what makes the story worth a closer look.
Why this matters right now
For income investors, the headline number is striking: £1, 000 buys 35 shares in Croda, a company that has stayed on its dividend path even after a long slide in sentiment. The motley fool uk framing matters because the question is not whether the stock has had a rough run; it clearly has. The more important issue is whether the business can keep translating its pricing power and regulatory protection into shareholder returns while its operating environment improves.
Croda’s products support agriculture, beauty products, and drugs, and the company benefits from high barriers to entry. In some cases, those barriers take the form of patents. In others, products are specified during approval processes, making substitution difficult. That structure gives Croda pricing power, but it has not protected the shares from a severe de-rating over the past five years.
What lies beneath the dividend record
The stock’s decline has been driven by more than one factor. Demand surged during the pandemic, lifting both the business and the share price. Since then, customers have been working through excess inventories, and Croda also made strategic moves that did not work as intended. Its investment of Covid-19 windfall gains into the lipids division is described as a mistake, and that misstep helped turn a boom into a bust.
That is the central tension in the motley fool uk analysis: a strong long-term dividend record does not erase operational errors. Croda has lifted its dividend every year for over 30 consecutive years, a record that spans recessions, wars, and several changes of leadership. But the most recent increase was minimal, and the dividend was barely covered by free cash flow. That makes the sustainability of further growth dependent on a recovery in trading conditions.
There are, however, early signs that the environment may be turning. Croda’s latest update pointed to normalising inventory levels, which should support demand after a prolonged period of weakness. That is not a guarantee of a rapid rebound, but it does suggest the worst of the inventory overhang may be easing.
Expert perspectives on risk, discipline, and patience
The lesson Croda offers is not simply that income stocks can be resilient. It is that investors must separate cyclical strength from structural change. The company’s pandemic-era surge made it easier to believe that a higher level of demand was permanent. It was not. That is a reminder that even quality businesses can become expensive stories if investors mistake a temporary high for a durable shift.
Another lesson is the risk of complexity. Croda’s strategic shift faltered because it misread the future of drug development. That does not mean complex industries should be avoided altogether, but it does mean the burden on investors is higher when business models depend on technical assumptions and long product cycles. The motley fool uk coverage highlights that kind of uncertainty rather than disguising it.
Regional and global impact for income investors
For UK investors, Croda’s case sits alongside a broader debate over where dependable income should come from. Lloyds Banking Group has delivered a very different story, with a 2025 dividend rise of 15. 2% and a share price up nearly 80% since the start of 2025. Yet Lloyds also illustrates how quickly valuation questions can return after a strong rally, especially when future growth depends heavily on a subdued British economy.
The comparison is useful because it shows two distinct forms of income risk. Croda carries operational and recovery risk after years of disappointment. Lloyds carries valuation and macroeconomic risk after a powerful rebound. In both cases, the investor must judge whether the income stream is backed by durable fundamentals or simply by a favourable moment in the cycle.
That is why the motley fool uk discussion goes beyond the simple calculation of how many shares £1, 000 can buy. It points to a deeper question about whether reliable dividends are more valuable when a business is under pressure than when it is already popular. If Croda’s inventory recovery continues and cash flow improves, today’s battered share price could look very different in hindsight. But if the recovery stalls, the dividend record may prove less reassuring than it first appears. Which matters more to long-term investors: the strength of the income today, or the quality of the business behind it?
